iiinova — where your digital self keeps evolving

A new blind challenge is coming! In two weeks #OpenBind, @openadmet.bsky.social & #ASAP Consortium are challenging the community to predict protein-ligand binding for the Zika virus NS2B-NS3 protease. Get the details and start preparing: loom.ly/Q76qOI0

011

OpenBind @openbind.bsky.social · 21/08/2026

Following the release of #Openbind's first #AI model, our latest blog takes a deeper dive into the science behind it, including benchmarking, training data, model updates, and access to code and datasets for reproducible research. loom.ly/sRph01k

010

OpenBind @openbind.bsky.social · 21/08/2026

OpenBind's first AI model is now live! Built on #OpenBind's open protein-ligand binding datasets, and machine learning, the model helps researchers identify promising drug candidates faster and supports more data-driven drug discovery. loom.ly/X97SzJc #OpenScience #AI #DrugDiscovery

022

OpenBind @openbind.bsky.social · 19/08/2026

#OpenBind has successfully secured funding, marking a significant milestone in the initiative’s mission to transform #DrugDiscovery through #ArtificialIntelligence. loom.ly/Fm1cIIk

010

OpenBind @openbind.bsky.social · 24/06/2026

How can AI help us design new drugs? This Oxford Sparks podcast features Prof Fergus Imrie on data + machine learning to predict how molecules bind to proteins - a key step in #DrugDiscovery & central to #OpenBind's aim to build a huge open dataset to power #AI in this space loom.ly/PViDwoU

020

Reposted by OpenBind

Rosetta Commons @rosettacommons.bsky.social · 17/06/2026

OpenBind is generating high-quality protein-ligand datasets that link structural data with binding measurements. This first release provides a realistic, structurally novel testbed linking high-resolution crystallographic data directly with biophysical binding affinity. zurl.co/PVCnJ

2114

Reposted by OpenBind

Department of Statistics @oxfordstatistics.bsky.social · 13/05/2026

📢 A milestone for AI-driven drug discovery Researchers from the department, as part of the @openbind.bsky.social consortium, have helped release a major new open dataset and predictive AI model to strengthen the data foundations for AI in drug discovery. Read more: tinyurl.com/2j9u44mw

Dr Lizbé Koekemoer, Centre for Medicines Discovery, University of Oxford, and Dr Jasmin Aschenbrenner, Diamond Light Source, reviewing a molecular structure in the Diamond laboratory.

Credit: Stuart March – DNDi.

021

Reposted by OpenBind

University of Oxford @ox.ac.uk · 14/05/2026

The OpenBind consortium’s first release of experimental data marks a milestone in efforts to improve how artificial intelligence (AI) is used in drug discovery. Find out more ⬇️ www.ox.ac.uk/news/2026-05-12-openbi…

The image shows a colourful abstract scientific visualisation featuring ribbon-like protein structures, molecular models and translucent flowing forms in bright shades of orange, blue, yellow and pink. Overlaid text reads: “OpenBind releases first open dataset and AI model for drug discovery” alongside University of Oxford branding.

0106

OpenBind @openbind.bsky.social · 13/05/2026

Our latest blog walks through how the affinity and kinetics data in the EV‑A71 2A OpenBind release were produced - from target selection to large‑scale structure and binding measurements. loom.ly/gZY5ylY #StructuralBiology #Biophysics #OpenScience #AI

0102

OpenBind @openbind.bsky.social · 11/05/2026

Our latest blog takes a behind‑the‑scenes look at the experimental and structural biology work behind #OpenBind’s first data release - from protein production to crystallographic model building and refinement. loom.ly/Ydcti7A #StructuralBiology #Crystallography #OpenScience

032

OpenBind @openbind.bsky.social · 08/05/2026

The latest blog from #OpenBind introduces a new structure–affinity dataset for the EV‑A71 2A protease, alongside reference benchmarks and guidance on how the community can use and evaluate it across docking, co‑folding, and affinity prediction. loom.ly/6xPIRUc #OpenScience #DrugDiscovery #AI

042

OpenBind @openbind.bsky.social · 06/05/2026

#OpenBind announces its first data drop marking a major milestone for AI‑Enabled #DrugDiscovery! It’s the first initiative to generate open, AI‑ready datasets for protein–drug complexes, produced continuously & at industrial scale to enable the next generation of #AI models. loom.ly/eIrsqqg

1168

OpenBind @openbind.bsky.social · 05/05/2026

Heading to the OpenFold Summit in Barcelona? Come and meet the OpenBind team and learn more about our first data release.

020

OpenBind @openbind.bsky.social · 17/04/2026

Sovereign AI officially launched yesterday to put Britain at the forefront of #AI. Supporting #OpenBind in its foundation phase, the £8 million seed fund will enable datasets for protein-drug complexes at an industrial scale, specifically for #AI to speed up #DrugDiscovery. loom.ly/eHc59cA

linkedin.com

Sovereign AI. Launching Tonight.🇬🇧 | Sovereign AI | 16 comments

Sovereign AI. Launching Tonight.🇬🇧 | 16 comments on LinkedIn

031

OpenBind @openbind.bsky.social · 09/04/2026

Curious about #AI driven protein-ligand modelling and the role of #OpenBind? If you’re at #DrugDiscoveryChemistry next week, come along to this session in the Generative AI & Predictive Modelling track to find out more. loom.ly/6kqUfSE

021

OpenBind @openbind.bsky.social · 02/03/2026

Good to see #OpenBind referenced in the UK’s AI for Science Strategy, highlighting the importance of open, #AI‑ready data in accelerating drug discovery. loom.ly/Rxt5JL8

051

OpenBind @openbind.bsky.social · 22/01/2026

AI is only as powerful as the data behind it! Listen to Charlotte Deane at @oxfordstatistics.bsky.social explain how #OpenBind has the power to unlock a large number of reliable datasets to drive the next wave of #AI-enabled #DrugDiscovery.

030

OpenBind @openbind.bsky.social · 21/01/2026

Exciting news for #OpenBind! Ali Ebrahim will be working with the #XChem team at Diamond to help analyse and curate structural data for our data‑release packages and software, boosting the quality and utility of ML training sets. Welcome aboard, Ali! loom.ly/Vro7Lo8

000

OpenBind @openbind.bsky.social · 16/01/2026

#OpenBind has installed three new Crystal Shifter instruments to support Diamond Light Source’s #XChem #FragmentScreening and help drive the next generation of ML‑powered structure‑based #drug design. loom.ly/RRLB3V0),

000

Reposted by OpenBind

Diamond Industrial Liaison Group @diamondilo.bsky.social · 13/01/2026

At #CCP4 Study Weekend, Jasmin Aschenbrenner showcased #OpenBind - an initiative creating high-quality #FragmentScreening data at Diamond to power next-gen machine learning for #DrugDiscovery. Learn more about this initiative: Website: www.openbind.org Bluesky: @openbind.bsky.social

031

OpenBind @openbind.bsky.social · 14/01/2026

A big welcome to Jochem Nelen, who will be joining the #OpenBind initiative. Working with Fergus Imrie and Charlotte Deane at the University of Oxford to apply computational methods for better hit discovery and screening. loom.ly/Vro7Lo8 #OpenBind #DrugDiscovery #AI

000

OpenBind @openbind.bsky.social · 13/01/2026

Excited to welcome Ben Sattelle to the OpenBind team! Ben will be working at MedChemica to link MCPairs with SCARAB, driving AI-powered drug discovery and smarter molecular design. Find out more: loom.ly/Vro7Lo8 #OpenBind #DrugDiscovery #AI

000

OpenBind @openbind.bsky.social · 09/01/2026

We've completed the first experimental phasing cycle!

000

OpenBind @openbind.bsky.social · 07/01/2026

Heading to #CCP4 this week? Discover #OpenBind, an open science initiative transforming structure-based drug design. Join Fergus Imrie (University of Oxford) on Friday, 11:00–11:30, to learn how OpenBind powers next-generation machine learning for #DrugDiscovery: loom.ly/KxbknFk

010

OpenBind @openbind.bsky.social · 06/01/2026

Join our mailing list for early access to AI-driven drug discovery insights & breakthroughs through the #OpenBind initiative. loom.ly/Vro7Lo8

031